According to Akebia Therapeutics's latest financial reports the company's current revenue (TTM ) is NZ$0.29 Billion. In 2023 the company made a revenue of NZ$0.30 Billion a decrease over the revenue in the year 2022 that were of NZ$0.45 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2024 (TTM) | NZ$0.27 B | -10.93% |
2023 | NZ$0.30 B | -33.08% |
2022 | NZ$0.45 B | 47.06% |
2021 | NZ$0.31 B | -23.6% |
2020 | NZ$0.40 B | -17.72% |
2019 | NZ$0.49 B | 60.61% |
2018 | NZ$0.30 B | 23.58% |
2017 | NZ$0.25 B | 11209.12% |
2016 | NZ$2.21 M | |
2015 | N/A | |
2014 | N/A | |
2013 | N/A |